CRSP vs VRTX
CRSP and VRTX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRSPCRISPR THERAPEUTICS AG | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| Market cap | $4.82B | $140.15B |
| P/E (TTM) | — | 32.2 |
| P/B | — | 6.92 |
| P/S | 1390.1x | 11.9x |
| Revenue | — | $12.59B(TTM) |
| Revenue growth (YoY) | -90.6% | 8.9% |
| Net income | — | $4.41B(TTM) |
| Earnings growth (YoY) | -58.8% | 838.1% |
| EPS, diluted | — | $17.17(TTM) |
| EBIT margin | -18933.6% | 34.8% |
| ROE | -33.3% | 19.5% |
| ROIC | -32.6% | 25.0% |
| 1y total return | -21.1% | +32.4% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRSP frente a VRTX
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)